Overview

This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders.  Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.

Full Product Details

9783319160177

Table of Contents

Reviews

Author Information

Filipe Palavra, MD Laboratory of Pharmacology and Experimental Therapeutics Institute for Biomedical Imaging and Life Sciences (IBILI) Faculty of Medicine, Coimbra University Coimbra, Portugal  Flávio Reis, PhD Laboratory of Pharmacology and Experimental Therapeutics Institute for Biomedical Imaging and Life Sciences (IBILI) Faculty of Medicine, Coimbra University Coimbra, Portugal  Daniela Marado, MD Department of Internal Medicine – B Centro Hospitalar e Universitário de Coimbra Coimbra, Portugal  Armando Sena, MD, PhD Interdisciplinary Centre of Research Egas Moniz, CiiEM Caparica, Portugal

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available